Nuclea Diagnostics Laboratories LLC, a part of Nuclea Biotechnologies, Inc., develops a wide range of tests to measure oncogenes, growth factors and growth factor receptors as well as other biomarkers. Our focus is on developing and manufacturing new biomarker assays for use as companion diagnostics. Our in vitro diagnostic assays (Oncogene Science Product line) are used by pharmaceutical, reference laboratories and clinical researchers. Nuclea Diagnostics is located at the Cambridge Discovery Park, near Alewife Station in Cambridge, MA.



For more information, visit www.nucleabio.com or www.her2bloodtest.com


 

Along with our selection of research use only kits, we strive to provide the medical community reliable in vitro diagnostics, such as our Serum HER-2/neu ELISA test, for the monitoring and management of patient care. Please visit our Products page to learn about our high quality tests for measuring oncogenes, growth factor receptors (HER-2, EGFr), proteases and protease inhibitors (uPA, PAI-1, TIMP-1), as well as markers of hypoxia (CA IX).



Learn more about the Serum HER-2/neu ELISA Test as an additional tool to help manage metastatic breast cancer

 

read: 1 | today: 1